Argentina Intravenous Solutions Market Overview, 2030

In Argentina's leading hospitals from Buenos Aires to Córdoba sterile vein-administered fluids have evolved from early hospital-ward drips to advanced nutrient and electrolyte therapies. Beginning mid-20th century, clinicians first used simple saline infusions to treat dehydration and support surgical recovery, but they soon dealt with inconsistent solution purity and contamination risks. Producers addressed these issues by introducing factory-sealed formulations, including balanced salts, parenteral nutrition (both central and peripheral), lipid emulsions, and medication-enhanced packs. They are manufactured under strict clean-room protocols involving multi-stage filtration, heat sterilization, and aseptic bag filling. Healthcare teams now use these fluids in public and private hospitals, outpatient clinics, oncology and dialysis units, emergency rooms, and an emerging home-infusion segment. These blends supply essential fluids, minerals, glucose, lipids, medications, and vitamins directly into veins to restore hydration, correct electrolyte imbalances, support blood pressure stability, aid surgical recovery, and nourish patients unable to digest food. Over the past two decades, Argentina has embraced PVC-free bags, dual-chamber systems for combined nutrient and electrolyte administration, and smart infusion pumps with dosage alerts. Domestic development of clean-room facilities in Buenos Aires and Rosario supported by ANMAT regulations and Ministry of Health innovation grants reduced reliance on imports following early setbacks in adopting complex parenteral nutrition blends. Transfer agreements with European and U.S. firms improved aseptic protocols and calibration methods. Local R&D led by CONICET and specialized hospitals improved formula resilience against contamination and ensured stable storage under regional temperature variations. These efforts enabled certified production hubs that secured faster approvals and reliable supply across government hospitals and expanding private networks.

According to the research report ""Argentina Intravenous Solutions Market Overview, 2030,"" published by Bonafide Research, the Argentina Intravenous Solutions market was valued at more than USD 110 Million in 2025.The market growth is driven a rising chronic disease burden (especially cancer, kidney disorders, and diabetes), expansion of outpatient and home-infusion services, and increasing uptake of nutrient-rich wellness drips among urban consumers. Argentina allocates about 10% of GDP to health well above regional averages which supports enhanced healthcare infrastructure with over 5,000 clinics and hospitals nationwide. During the COVID-19 pandemic, disruptions in import of bag films and filters affected production, but ANMAT’s regulatory flexibility and local manufacturing expansion helped the industry rebound swiftly. Argentina sources polymer films and filters primarily from Brazil, the U.S., and Europe, while finished products are distributed throughout Latin America. Global firms including Fresenius, Baxter, Pfizer, Otsuka, and B. Braun dominate by offering pre-mixed nutrition and electrolyte bags, smart infusion devices, and integrations with hospital information systems. Domestic companies such as Grifols Argentina and InfusiMed supply region-specific formulations and Portuguese/Spanish‑labeled packs for local clinics. They still face challenges in expanding sterile production capacity and managing logistic costs, but they benefit from government subsidies under health‑production incentives. Third-party contract manufacturers and logistics services provide clean-room fill-finish, cold-chain distribution, and quality testing. Within Argentina, production centers are concentrated in Buenos Aires province and Santa Fe, while demand peaks in metropolitan hospitals and rural wellness centers.

The Argentina intravenous (IV) market, segmented by product type, mainly comprises Total Parenteral Nutrition (TPN) and Peripheral Parenteral Nutrition (PPN), both critical in delivering nutritional support to patients unable to meet their dietary needs orally or enterally. TPN dominates the market due to its essential role in providing comprehensive, long-term nutrition to patients with severe gastrointestinal conditions, cancer, critical illnesses, or those recovering from major surgeries. Administered through central venous catheters, TPN allows for high-concentration nutrient delivery and tailored formulations that meet complex metabolic and caloric demands. The growing burden of chronic diseases, increasing hospitalizations, and an aging population in Argentina are driving demand for TPN, especially within hospital and emerging homecare settings. However, challenges such as cost constraints and limited healthcare infrastructure in some regions can affect accessibility. Conversely, PPN is widely used for short-term or less severe nutritional supplementation, delivered through peripheral veins with lower nutrient concentration limits and fewer risks of complications such as infections. PPN is particularly suited for acute care scenarios or as a transitional solution to oral feeding. Argentina’s healthcare system is increasingly adopting both TPN and PPN as part of integrated nutritional care programs, supported by growing clinical awareness of malnutrition’s impact on recovery outcomes. Furthermore, advances in infusion technology and expanding home infusion services are broadening the availability of IV nutrition beyond hospitals. Despite regulatory and reimbursement challenges, the market for both TPN and PPN is expected to grow steadily, driven by increasing demand for quality healthcare and improved patient management strategies, with TPN maintaining the leading market share due to its indispensable role in complex patient care.

The Argentina intravenous (IV) nutrition market, segmented by composition, includes a broad range of essential nutrients designed to meet diverse clinical needs. Carbohydrates, primarily delivered as dextrose solutions, serve as the primary energy source in parenteral nutrition and are critical for supporting metabolic functions during recovery from surgery, trauma, or critical illness. The rise in surgical procedures and critical care admissions in Argentina sustains consistent demand for carbohydrates in IV formulations. Vitamins and minerals are crucial for maintaining immune function, metabolic balance, and preventing micronutrient deficiencies, often administered as part of multivitamin and trace element preparations tailored to local clinical guidelines. The use of single dose amino acids is fundamental for protein synthesis and tissue repair, particularly for oncology, elderly, and malnourished patients, a segment growing due to Argentina’s shifting demographics and healthcare focus. Parenteral lipid emulsions provide essential fatty acids and dense caloric intake, with the market gradually adopting advanced multi-source emulsions that combine soybean, olive, and fish oils to improve safety profiles and reduce inflammation, aligning with global clinical nutrition trends. The ‘Others’ category includes electrolytes, buffers, and specialized additives such as glutamine and antioxidants, allowing personalized nutrition therapies to optimize patient outcomes. Argentina’s evolving regulatory landscape, expanding hospital nutrition protocols, and increasing adoption of home infusion services support the growing use of these complex IV compositions. Investment in ready-to-use solutions and improved healthcare infrastructure is further enhancing product availability and safety, positioning the intravenous nutrition market for steady growth driven by clinical demand and innovation.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Intravenous Solutions Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition

By Composition
• Carbohydrates
• Vitamins and Minerals
• Single Dose Amino Acids
• Parenteral Lipid Emulsion
• Others Show more